
    
      1. This is a prospective, multicenter, randomized and noninferiority clinical trial, which
           is designed to compare the effectiveness and safety with the fully absorbable
           ventricular septal defect (VSD) occlusion system and VSD occlusion system produced by
           Shanghai shape memory alloy materials co., LTD.

        2. This trial will recruit about 108 subjects from 4 centers. Patients will be randomized
           to two groups in equal proportion (54 in each). The proposal recruiting period is 12
           months and the follow-up will be performed at 1 month, 3 months and 6 months after
           surgery.
    
  